• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Administration o gentamicin to obese patients.

作者信息

Korsager S

出版信息

Int J Clin Pharmacol Ther Toxicol. 1980 Dec;18(12):549-53.

PMID:7228450
Abstract

The relation beteen a single bolus dose of gentamicin and the subsequent concentration in serum was studied in 17 obese patients with 82.7% excess weight and in 10 normal-weight patients. The apparent volume of distribution (AVD) for gentamicin in the two groups was calculated. In the obese group the AVD (17.7%) was found to be significantly lower than in the normal-weight group (23.2%). The AVD for the adipose tissue and the lean body mass was calculated to be 10.3% and 31.0%, respectively. The uptake of gentamicin in adipose tissue was found to be 43.7% of the uptake in the total body mass of normal-weight patients. A formula which indicates an adjudged body weight is recommended when the proper dose of gentamicin for obese patients is calculated. The formula is recommended only in cases of severe obesity.

摘要

相似文献

1
Administration o gentamicin to obese patients.
Int J Clin Pharmacol Ther Toxicol. 1980 Dec;18(12):549-53.
2
Obesity as a risk factor in drug-induced organ injury. V. Toxicokinetics of gentamicin in the obese overfed rat.肥胖作为药物性器官损伤的一个风险因素。五、庆大霉素在肥胖过度喂养大鼠中的毒代动力学。
Drug Metab Dispos. 1992 May-Jun;20(3):402-6.
3
Altered gentamicin distribution in ascitic patients.腹水患者庆大霉素分布的改变。
Am J Hosp Pharm. 1979 Dec;36(12):1704-6.
4
Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.用于预测肥胖患者庆大霉素药代动力学值的肌酐清除率估计值。
Am J Hosp Pharm. 1994 Sep 1;51(17):2125-30.
5
[Expression of omentin in adipose tissues in obese and type 2 diabetic patients].[肥胖和2型糖尿病患者脂肪组织中网膜素的表达]
Zhonghua Yi Xue Za Zhi. 2009 Feb 17;89(6):381-4.
6
Regional muscle and adipose tissue amino acid metabolism in lean and obese women.瘦女性和肥胖女性的局部肌肉与脂肪组织氨基酸代谢
Am J Physiol Endocrinol Metab. 2002 Apr;282(4):E931-6. doi: 10.1152/ajpendo.00359.2001.
7
The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.年龄和化疗对儿科肿瘤患者庆大霉素药代动力学及给药剂量的影响。
Pharmacotherapy. 1995 Nov-Dec;15(6):754-64.
8
[Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].[评估不同内源性皮质醇水平人群血浆中瘦素水平及其对影响组织脂肪水平的其他激素因素的依赖性]
Ann Acad Med Stetin. 2002;48:283-300.
9
Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.庆大霉素在接受每日一次给药的住院患者中的群体药代动力学。
Int J Antimicrob Agents. 2004 Mar;23(3):291-5. doi: 10.1016/j.ijantimicag.2003.07.010.
10
[Body fat distribution: its characteristics and relationship to cardiovascular risk factors in obese Chinese].[体脂分布:肥胖中国人的特征及其与心血管危险因素的关系]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Sep;35(5):699-703.

引用本文的文献

1
Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review.各种患者人群中庆大霉素的临床药代动力学及治疗革兰氏阴性感染的最佳给药剂量的后果:更新综述。
Clin Pharmacokinet. 2022 Aug;61(8):1075-1094. doi: 10.1007/s40262-022-01143-0. Epub 2022 Jun 27.
2
Pharmacokinetics of Hormonal Contraception in Individuals with Obesity: a Review.肥胖个体中激素避孕的药代动力学:综述
Curr Obstet Gynecol Rep. 2020 Jun;9(2):72-78. doi: 10.1007/s13669-020-00284-y. Epub 2020 May 4.
3
Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study.
肥胖和非肥胖个体中,妥布霉素清除率最好通过肾功能估计值来描述:一项前瞻性丰富采样药代动力学研究的结果。
Pharm Res. 2019 May 30;36(8):112. doi: 10.1007/s11095-019-2651-2.
4
A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients.一项前瞻性临床研究,旨在探讨病态肥胖对庆大霉素药代动力学的影响:为肥胖患者实现个体化给药。
Clin Pharmacokinet. 2019 Oct;58(10):1333-1343. doi: 10.1007/s40262-019-00762-4.
5
Intravenous Push Administration of Antibiotics: Literature and Considerations.抗生素静脉推注给药:文献与考量
Hosp Pharm. 2018 Jun;53(3):157-169. doi: 10.1177/0018578718760257. Epub 2018 Mar 8.
6
Pharmacokinetic changes and dosing modification of aminoglycosides in critically ill obese patients: a literature review.危重症肥胖患者氨基糖苷类药物的药代动力学变化及剂量调整:文献综述
J Clin Med Res. 2014 Aug;6(4):227-33. doi: 10.14740/jocmr1858w. Epub 2014 May 22.
7
Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy.肥胖患者肾小球滤过率的测量:陷阱及对药物治疗的潜在影响。
Obes Facts. 2011;4(3):238-43. doi: 10.1159/000329547. Epub 2011 Jun 6.
8
Preventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens.预防减重手术后手术部位感染:围手术期抗生素方案的价值。
Expert Rev Pharmacoecon Outcomes Res. 2010 Jun;10(3):317-28. doi: 10.1586/erp.10.26.
9
Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.肥胖患者抗菌药物的剂量调整:应用临床药代动力学
Clin Pharmacokinet. 2000 May;38(5):415-26. doi: 10.2165/00003088-200038050-00003.
10
Pharmacokinetics of drugs in obesity.肥胖人群中药物的药代动力学
Clin Pharmacokinet. 1982 Mar-Apr;7(2):108-24. doi: 10.2165/00003088-198207020-00002.